Cargando…

Is De-escalated Bisphosphonates Therapy a Suitable Alternative to Standard Dosing in Malignant Tumor Patients With Bone Metastases: A Systematic Review and Meta-Analysis

Background: Previous studies have preliminarily identified the non-inferior efficacy for reducing skeletal-related event (SRE) rates between de-escalated (Q12w) and standard (Q3-4w) bone-targeting agents therapy in malignant tumor patients with bone metastases. In this study, we aim to make further...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Qiuhua, Men, Peng, Liu, Zhiyong, Zhai, Suodi, Jiang, Mingyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6702312/ https://www.ncbi.nlm.nih.gov/pubmed/31475116 http://dx.doi.org/10.3389/fonc.2019.00774

Ejemplares similares

Low radiotherapy dose is suitable for brain metastases in SCLC compared with high dose
por: Xu, Liming, et al.
Publicado: (2023)

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases
por: Addison, Christina L, et al.
Publicado: (2014)

Bisphosphonates and bone metastases.
por: Morton, A. R., et al.
Publicado: (1988)

Risk of Gastrointestinal Adverse Events in Cancer Patients Treated With Immune Checkpoint Inhibitor Plus Chemotherapy: A Systematic Review and Meta-Analysis
por: Yang, Wenhan, et al.
Publicado: (2020)

Feasibility of Dose Escalation in Patients With Intracranial Pediatric Ependymoma
por: Tensaouti, Fatima, et al.
Publicado: (2019)

Concomitant intraperitoneal and systemic chemotherapy for extensive peritoneal metastases of colorectal origin: protocol of the multicentre, open-label, phase I, dose-escalation INTERACT trial
por: de Boer, Nadine Leonie, et al.
Publicado: (2019)

A Systematic Review of Vancomycin Dosing in Patients with Hematologic Malignancies or Neutropenia
por: He, Na, et al.
Publicado: (2020)

Dose-Escalated Robotic SBRT for Stage I–II Prostate Cancer
por: Meier, Robert
Publicado: (2015)

Clinical Experience of Intra-tumoral Central-Dose Escalated Volumetric Modulated Arc Therapy for Lymph Node Metastases in Patients With Advanced Cancer
por: Fujiwara, Masateru, et al.
Publicado: (2023)

Radiation Dose Escalation in Stage III Non-Small-Cell Lung Cancer
por: Terakedis, Breanne, et al.
Publicado: (2011)

Optimizing Clinical Benefits of Bisphosphonates in Cancer Patients with Bone Metastases
por: Aapro, Matti, et al.
Publicado: (2010)

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases
por: Pfannkuchen, Nina, et al.
Publicado: (2017)

Editorial: Bone Metastases
por: Valenti, Maria Teresa, et al.
Publicado: (2021)

Clinical Characteristics and Prognosis of Renal Cell Carcinoma With Spinal Bone Metastases
por: Zhai, Jianpo, et al.
Publicado: (2021)

Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?
por: Statham, Louise, et al.
Publicado: (2020)

Bisphosphonates enhance antitumor effect of EGFR-TKIs in patients with advanced EGFR mutant NSCLC and bone metastases
por: Zhang, Guowei, et al.
Publicado: (2017)

Dose-escalated Radiotherapy with Simultaneous Integrated Boost for Bone Metastases in Selected Patients with Assumed Favourable Prognosis
por: Potkrajcic, Vlatko, et al.
Publicado: (2022)

Malignant pilomatricoma in a dog with local and distant metastases treated with chemotherapy and bisphosphonates
por: Treggiari, Elisabetta, et al.
Publicado: (2017)

Bisphosphonates in oncology: evidence for the prevention of skeletal events in patients with bone metastases
por: Polascik, Thomas J
Publicado: (2009)

Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
por: Zhang, Gao, et al.
Publicado: (2021)

Malignant Pheochromocytoma with Widespread Bony and Pulmonary Metastases
por: Muneer, Tazeen, et al.
Publicado: (2018)

Effects of de-escalated bisphosphonate therapy on the Functional Assessment of Cancer Therapy-Bone Pain, Brief Pain Inventory and bone biomarkers
por: Kuchuk, Iryna, et al.
Publicado: (2013)

Intrafraction Prostate Motion Management During Dose-Escalated Linac-Based Stereotactic Body Radiation Therapy
por: Panizza, Denis, et al.
Publicado: (2022)

Rationale for Utilization of Hydrogel Rectal Spacers in Dose Escalated SBRT for the Treatment of Unfavorable Risk Prostate Cancer
por: Repka, Michael C., et al.
Publicado: (2022)

Endoplasmic Reticulum Stress in Bone Metastases
por: Xu, Longyong, et al.
Publicado: (2020)

Management of pain in patients with bone metastases
por: Jing, Doudou, et al.
Publicado: (2023)

Editorial: Diagnosis and treatment of bone metastases
por: Pu, Feifei, et al.
Publicado: (2023)

Multimodality image fusion in dose escalation studies of brain tumors
por: Rajasekar, D., et al.
Publicado: (2000)

Definitive Chemoradiation With Dose Escalation for Locally Advanced Gastric Cancer: Case Studies
por: Anthony, Michelle, et al.
Publicado: (2020)

Retracted: Analysis of the Mechanism and Safety of Bisphosphonates in Patients with Lung Cancer and Bone Metastases
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Empagliflozin in Type 2 Diabetes Mellitus Patients with High Cardiovascular Risk: A Model-Based Cost-Utility Analysis in China
por: Men, Peng, et al.
Publicado: (2020)

Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer
por: Hepel, Jaroslaw T., et al.
Publicado: (2012)

Strategies of Dose Escalation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer: Image Guidance and Beyond
por: Chi, Alexander, et al.
Publicado: (2014)

Dose-Escalated Stereotactic Body Radiation Therapy for Prostate Cancer: Quality-of-Life Comparison of Two Prospective Trials
por: Quon, Harvey C., et al.
Publicado: (2016)

Dose escalation via brachytherapy boost for nasopharyngeal carcinoma in the era of intensity-modulated radiation therapy and combined chemotherapy
por: Chao, Hsing-Lung, et al.
Publicado: (2017)

Locally Advanced Non Small Cell Lung Cancer: The Case for Radiation Dose De-escalation in the Management of the Mediastinum
por: Soyfer, Viacheslav, et al.
Publicado: (2019)

Potential biomarkers for the early detection of bone metastases
por: Hao, Yang, et al.
Publicado: (2023)

Potential Applications of Image-Guided Radiotherapy for Radiation Dose Escalation in Patients with Early Stage High-Risk Prostate Cancer
por: Nguyen, Nam P., et al.
Publicado: (2015)

Target Coverage and Normal Organ Sparing in Dose-Escalated Total Marrow and Lymphatic Irradiation: A Single-Institution Experience
por: Han, Chunhui, et al.
Publicado: (2022)

Optimal dose-fractionation schedule of palliative radiotherapy for patients with bone metastases: a protocol for systematic review and network meta-analysis
por: Tang, Xiaofang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4u127htdd4vdpu3ani8toesh5k